Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125801484 | 12580148 | 4 | F | 201606 | 20160810 | 20160721 | 20160818 | EXP | US-BAYER-2016-137008 | BAYER | 34.00 | YR | A | M | Y | 81.63000 | KG | 20160818 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125801484 | 12580148 | 1 | PS | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 0.062 MG, QOD, ON WEEKS 1 AND 2 | U | 103471 | .062 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD | |||||
| 125801484 | 12580148 | 2 | SS | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 0.125 MG, QOD, ON WEEKS 3 AND 4 | U | 103471 | .125 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD | |||||
| 125801484 | 12580148 | 3 | SS | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 0.187 MG, QOD, ON WEEKS 5 AND 6 | U | 103471 | .187 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD | |||||
| 125801484 | 12580148 | 4 | SS | BETASERON | INTERFERON BETA-1B | 1 | Subcutaneous | 0.25 MG, QOD, WEEK 7 | U | 103471 | .25 | MG | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125801484 | 12580148 | 1 | Multiple sclerosis |
| 125801484 | 12580148 | 2 | Multiple sclerosis |
| 125801484 | 12580148 | 3 | Multiple sclerosis |
| 125801484 | 12580148 | 4 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125801484 | 12580148 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125801484 | 12580148 | Arthropathy | |
| 125801484 | 12580148 | Dizziness | |
| 125801484 | 12580148 | Fall | |
| 125801484 | 12580148 | Injection site bruising | |
| 125801484 | 12580148 | Muscular weakness | |
| 125801484 | 12580148 | Pain in extremity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125801484 | 12580148 | 1 | 201606 | 0 | ||
| 125801484 | 12580148 | 2 | 201606 | 0 | ||
| 125801484 | 12580148 | 3 | 201607 | 0 | ||
| 125801484 | 12580148 | 4 | 201606 | 0 |